Cypherpunk earns USD 39.39 million: what it means for Cypherpunk Technologies stock
Published on 10/27/2026 at 18:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSCypherpunk earnings and market position
- Cypherpunk Technologies reported USD 39.39 million net income for the second quarter ended June 30, 2026.
- The company held 323,394.38 ZEC as of August 11, 2026.
- Cypherpunk Technologies stock costs EUR 2.84 at Lang & Schwarz on October 27, 2026 at 6:50 p.m. CEST.
Cypherpunk Technologies (US52187K2006) reported USD 39.39 million of net income for the second quarter ended June 30, 2026, compared with a USD 16.64 million net loss in the prior-year quarter, according to Cypherpunk Technologies on August 12, 2026. The result was driven mainly by a USD 46.0 million unrealized gain on ZEC treasury holdings. Cypherpunk Technologies stock was at EUR 2.84 at Lang & Schwarz on October 27, 2026 at 6:50 p.m. CEST.
What the profit means
The earnings swing was tied to digital-asset valuation rather than commercial sales. The company reported diluted earnings per share of USD 0.18 for the second quarter, while research and development expenses fell to USD 0.2 million from USD 10.5 million in the prior-year quarter.
The treasury strategy is now central to the investment case. Cypherpunk held 323,394.38 ZEC as of August 11, 2026, at an average purchase price of USD 341.83 per ZEC, according to the company release.
Price position and analyst target
Finance data placed the Nasdaq-listed stock at USD 3.15 on October 27, 2026 at 1:52 p.m. ET, with a market capitalization of USD 339.6 million. Its 52-week range was USD 0.39 to USD 4.19, and volume reached 8,111,507 shares.
MarketBeat reported that Cantor Fitzgerald raised its target from USD 1.60 to USD 4.90 and kept an Overweight rating in a September 10, 2026 research note. The target is 55.56 percent above the USD 3.15 Nasdaq price.
Cash, assets and trading
Cash and cash equivalents totaled USD 7.6 million on June 30, 2026, while digital-asset receivables stood at USD 129.4 million based on the ZEC price at that date. The company also said its Leap Therapeutics subsidiary had reached FDA alignment on a proposed Phase 3 trial, with approximately 270 patients expected in the planned study.
The company release also highlighted the risk profile: ZEC price changes can materially affect reported earnings, while the planned clinical program still depends on financing and regulatory progress.
Cypherpunk stock at a glance
Cypherpunk Technologies combines a Zcash treasury with privacy technology investments and a biotechnology subsidiary. Its second-quarter profit therefore reflects both digital-asset prices and operating decisions, rather than recurring product revenue alone.
Cypherpunk Technologies stock was trading at EUR 2.84 at Lang & Schwarz on October 27, 2026 at 6:50 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Cypherpunk Technologies stock.
Cypherpunk Technologies market data
- Company: Cypherpunk Technologies Inc.
- ISIN: US52187K2006
- Ticker: CYPH
- Primary exchange: Nasdaq
- Price Lang & Schwarz (as of October 27, 2026, 6:50 p.m. CEST): EUR 2.84
- Market capitalization: USD 339.6 million (as of October 27, 2026)
- 52-week range: USD 0.39-USD 4.19 (as of October 27, 2026)
- Sector / Industry: Information technology / digital assets and blockchain technology
Market context: Market report Nasdaq Composite.
